Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1995;77:679-683

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suzuki, S.
Right arrow Articles by Chalmers, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suzuki, S.
Right arrow Articles by Chalmers, J.
(Circulation Research. 1995;77:679-683.)
© 1995 American Heart Association, Inc.


Articles

Antisense to Thyrotropin Releasing Hormone Receptor Reduces Arterial Blood Pressure in Spontaneously Hypertensive Rats

Satoshi Suzuki, Paul Pilowsky, Jane Minson, Leonard Arnolda, Ida Llewellyn-Smith, John Chalmers

From the Department of Medicine and Centre for Neuroscience, Flinders Medical Centre, Adelaide, Australia.

Correspondence to Dr Paul Pilowsky, Department of Medicine, Flinders Medical Centre, Adelaide, South Australia 5042, Australia. E-mail paul.pilowsky@flinders.edu.au.

Abstract We report in the present study the effect of intrathecal treatment with antisense oligonucleotides complementary to thyrotropin releasing hormone (TRH) receptor mRNA on the pressor response to intrathecal administration of TRH and on resting arterial blood pressure in Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHR). In 16-week-old male WKY rats, 18-base phosphodiester antisense or mismatch oligonucleotides to TRH receptor mRNA (100 µg per day) were injected intrathecally for 3 days. Twenty-four hours after the last injection, the magnitude of the pressor response to intrathecal TRH (10 µg) was significantly smaller in the antisense-treated group (n=7) compared with mismatch-treated controls (n=7) (change in mean arterial pressure, +20.3±3.0 versus +32.6±2.5 mm Hg, P<.01). No differences were observed in the pressor responses to injection of N-methyl-D-aspartic acid. Resting arterial blood pressure was unaffected by antisense treatment in WKY rats. In separate experiments, 16-week-old male SHR were treated with antisense (n=7) or mismatch (n=6) oligonucleotides for 3 days. Mean resting arterial blood pressure was significantly reduced by treatment with antisense oligonucleotides (from 157±4.8 to 119±8.8 mm Hg, P<.01), but no significant changes were observed in mismatch-treated animals. Our results suggest that the expression of TRH receptors in spinal sympathetic preganglionic neurons can be selectively reduced by intrathecal treatment with antisense oligonucleotides and that TRH projections to sympathetic preganglionic neurons play an important role in the elevation of arterial blood pressure in SHR.


Key Words: intrathecal • sympathetic preganglionic neurons • N-methyl-D-aspartic acid • oligonucleotides




This article has been cited by other articles:


Home page
HypertensionHome page
O. Gumieniak, T. S. Perlstein, J. S. Williams, P. N. Hopkins, N. J. Brown, B. A. Raby, and G. H. Williams
Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension
Hypertension, March 1, 2007; 49(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
O. Gumieniak, S. Hurwitz, T. S. Perlstein, U. C. Ngumezi, P. N. Hopkins, X. Jeunemaitre, and G. H. Williams
Aggregation of High-Normal Thyroid-Stimulating Hormone in Hypertensive Families
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 5985 - 5990.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. I. Phillips
Gene Therapy for Hypertension: The Preclinical Data
Hypertension, September 1, 2001; 38(3): 543 - 548.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. I. Garcia, A. L. Alvarez, P. I. Porto, V. M. Garfunkel, S. Finkielman, and C. J. Pirola
Antisense Inhibition of Thyrotropin-Releasing Hormone Reduces Arterial Blood Pressure in Spontaneously Hypertensive Rats
Hypertension, February 1, 2001; 37(2): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. I. Phillips
Is Gene Therapy for Hypertension Possible?
Hypertension, January 1, 1999; 33(1): 8 - 13.
[Full Text] [PDF]


Home page
EndocrinologyHome page
V. Martinez, S. V. Wu, and Y. Tache
Intracisternal Antisense Oligodeoxynucleotides to the Thyrotropin-Releasing Hormone Receptor Blocked Vagal-Dependent Stimulation of Gastric Emptying Induced by Acute Cold in Rats
Endocrinology, September 1, 1998; 139(9): 3730 - 3735.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
M. Kolaj, S. J. Shefchyk, and L. P. Renaud
Two Conductances Mediate Thyrotropin-Releasing-Hormone-Induced Depolarization of Neonatal Rat Spinal Preganglionic and Lateral Horn Neurons
J Neurophysiol, September 1, 1997; 78(3): 1726 - 1729.
[Abstract] [Full Text] [PDF]